From: Body mass index (BMI) may be a prognostic factor for gastric cancer with peritoneal dissemination
Variable | HR | 95% CI | p value |
---|---|---|---|
OS in gastric cancer patients | |||
Palliative gastrectomy (Gastrectomy vs. without gastrectomy)a | 0.689 | 0.540–0.879 | 0.003 |
Tumor size (<5, ≥5, and <10 vs. ≥10 cm) | 1.176 | 0.999–1.383 | 0.051 |
Tumor location (Upper, middle, and lower vs. total) | 1.080 | 0.962–1.213 | 0.192 |
Ascite (With vs. without) | 1.026 | 0.817–1.288 | 0.827 |
Peritoneal seeding grade (P1 and P2 vs. P3) | 1.298 | 1.124–1.500 | < 0.001 |
Serum CEA Level (Normal vs. elevated) | 1.424 | 1.120–1.810 | 0.004 |
Serum CA19-9 Level (Normal vs. elevated) | 1.133 | 0.900–1.424 | 0.287 |
Palliative chemotherapy (With vs. without) | 0.399 | 0.314–0.506 | < 0.001 |
BMI group (<18.5 and 18.5–23 vs. >23) | 0.812 | 0.686–0.962 | 0.016 |